It is a committee proposal in a draft spending bill — not enacted law — and the panel has not yet scheduled votes on it.
The Senate Appropriations Committee is proposing to extend a long-standing federal protection for state medical marijuana programs, while declining to adopt a House proposal that would block federal officials from advancing cannabis rescheduling. The language appears in the Fiscal Year 2027 Commerce, Justice, Science, and Related Agencies (CJS) spending bill the committee posted on Thursday. The status of the measure needs to be stated exactly: it is a panel proposal contained in a draft appropriations bill. The committee has not yet scheduled votes on any of the measures, nothing in it has passed Congress, and nothing in it has been enacted into law.
The Protection Itself: Section 531
The core of the proposal is an updated version of a rider that has been federal law since 2014 — the provision first enacted that December through what was then known as the Rohrabacher-Farr Amendment. Section 531 of the Senate bill provides that none of the funds made available under the act to the Department of Justice may be used, with respect to the states listed and the District of Columbia, the Commonwealth of the Northern Mariana Islands, the United States Virgin Islands, Guam and Puerto Rico, “to prevent any of them from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.”
The Marijuana Herald, reporting on the same bill, counts the coverage at 48 states, Washington, D.C., and four U.S. territories through September 2027, with Idaho and Kansas the only two states not included in the provision. The bill is a 141-page measure, one of five annual spending bills the committee released on November 12. Because the rider works by restricting how appropriated money may be spent, it does not legalize medical marijuana at the federal level and does not change any state’s law. What it does, when versions of it have been enacted in past spending bills, is bar the Justice Department from spending federal funds to interfere with the state programs on the list. Until a new bill is enacted, the existing protections remain in effect under a temporary government funding measure signed by President Trump in September — a measure the Herald reports expires December 11, leaving Congress less than a month to reach agreement on spending or approve another extension.
What The Senate Version Leaves Out
The news in this bill is as much about two omissions as about the rider itself. First, the Senate panel’s version does not include a new section the House Appropriations Committee proposed adding in May, which would have stipulated that the Justice Department can still enforce a section of U.S. code calling for increased penalties for distributing cannabis within 1,000 feet of an elementary school, vocational school, college, playground or public housing unit. The Herald describes the same difference from the House side: the House proposal, H.R. 8845, includes an exception to the medical marijuana protections for distribution or manufacturing near schools and colleges, and the Senate bill does not include that exception.
Second, and more consequentially for federal cannabis policy, the Senate committee is declining to align with the House on a provision that would block federal officials from taking further steps to carry out cannabis rescheduling. The House language would provide that no federal funds appropriated under the bill could be “used to reschedule marijuana…or to remove marijuana from the schedules” of the Controlled Substances Act. No such language appears in the Senate version. The backdrop, as Marijuana Moment reports it, is that the Trump administration has already moved state-licensed medical marijuana from Schedule I of the CSA to Schedule III — the Herald dates that Justice Department order to nearly seven months ago, covering state-licensed medical marijuana and FDA-approved marijuana products — while a Drug Enforcement Administration hearing is considering more broadly moving marijuana to Schedule III. The practical meaning of the Senate omission is narrow and should not be overstated: the proposed Senate bill, if enacted as written, would not itself reschedule anything. It simply would not use the spending bill to stop the separate rescheduling process.
The Rest Of The Cannabis Language
The CJS bill carries a second longstanding rider at Section 530, protecting state hemp research programs by barring funds from being used in contravention of section 7606 of the Agricultural Act of 2014, the “Legitimacy of Industrial Hemp Research” provision, by the Justice Department or the DEA. The committee report attached to the bill adds two oversight directives. One directs the Justice Department to submit a report to Congress, within 90 days of the act’s enactment, assessing illegal marijuana growing operations associated with foreign nationals — coordinated among the FBI, the DEA and the Executive Office for United States Attorneys, assessing the extent of such operations, any links to Chinese transnational criminal organizations and/or the government of the People’s Republic of China, and the federal resources available to support state, local and Tribal law enforcement. Another directs the DEA to brief Congress within 60 days of enactment on kratom-related issues, following a 2025 Department of Health and Human Services referral of a kratom byproduct to the DEA for possible scheduling, covering health and safety impacts, patterns of use, adverse events and any enforcement or regulatory actions taken.
A related directive sits in a different bill. A report attached to separate Department of Homeland Security funding legislation the committee released Thursday directs Customs and Border Protection to brief Congress, within 120 days of enactment, on its seizures of marijuana products — including products possessed, sold or transferred by distributors in compliance with applicable state or Tribal law. Marijuana Moment notes that CBP seizures from state-legal businesses have been the subject of litigation and criticism from New Mexico Governor Michelle Lujan Grisham. Earlier in the same week, the committee released other funding bills and reports directing agencies to consider medical marijuana as an opioid alternative and the therapeutic benefits of psychedelics, encouraging hemp cultivar and germplasm development, and raising concerns about cannabinoid-infused foods.
What Happens Next
Everything described here is at the proposal stage. The Senate Appropriations Committee has posted its bills and reports; it has not, Marijuana Moment reports, yet scheduled votes on any of the measures. For the medical marijuana rider to continue past the current temporary funding measure, a version of the spending legislation would need to pass both chambers and be signed — and the December 11 expiration of the current funding measure is the nearest deadline in that process. Readers should hold the distinction this story opened with: a Senate panel has proposed extending the state medical marijuana protections, without the House’s anti-rescheduling provision. That is a significant signal about where the appropriations process stands. It is not, yet, a change in the law.
The post Senate Panel Proposes Extending State Medical Marijuana Protections Without House Anti-Rescheduling Provision appeared first on The Hype Magazine.

6 days ago
11
